These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19121696)

  • 1. Induction of protective immunity against Burkholderia pseudomallei using attenuated mutants with defects in the intracellular life cycle.
    Breitbach K; Köhler J; Steinmetz I
    Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S89-94. PubMed ID: 19121696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.
    Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW
    Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice.
    Su YC; Wan KL; Mohamed R; Nathan S
    Vaccine; 2010 Jul; 28(31):5005-11. PubMed ID: 20546831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine.
    Silva EB; Goodyear A; Sutherland MD; Podnecky NL; Gonzalez-Juarrero M; Schweizer HP; Dow SW
    Infect Immun; 2013 Dec; 81(12):4626-34. PubMed ID: 24101688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterologously type IV pilus expressed protein of Burkholderia pseudomallei is immunogenic but fails to induce protective immunity in mice.
    Sangdee K; Waropastrakul S; Wongratanachewin S; Homchampa P
    Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1190-6. PubMed ID: 22299445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and characterization of an unmarked aroC deletion mutant of Burkholderia pseudomallei strain A2.
    Srilunchang T; Proungvitaya T; Wongratanacheewin S; Strugnell R; Homchampa P
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):123-30. PubMed ID: 19323044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burkholderia pseudomallei Δ
    Khakhum N; Bharaj P; Myers JN; Tapia D; Kilgore PB; Ross BN; Walker DH; Endsley JJ; Torres AG
    mSphere; 2019 Jan; 4(1):. PubMed ID: 30602524
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the protective effects of killed Burkholderia pseudomallei and CpG oligodeoxynucleotide against live challenge.
    Puangpetch A; Anderson R; Huang YY; Saengsot R; Sermswan RW; Wongratanacheewin S
    Vaccine; 2014 Oct; 32(45):5983-8. PubMed ID: 25223269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Burkholderia pseudomallei genes required for the intracellular life cycle and in vivo virulence.
    Pilatz S; Breitbach K; Hein N; Fehlhaber B; Schulze J; Brenneke B; Eberl L; Steinmetz I
    Infect Immun; 2006 Jun; 74(6):3576-86. PubMed ID: 16714590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed T
    Tapia D; Sanchez-Villamil JI; Stevenson HL; Torres AG
    mBio; 2021 Jun; 12(3):e0122721. PubMed ID: 34182777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents.
    Druar C; Yu F; Barnes JL; Okinaka RT; Chantratita N; Beg S; Stratilo CW; Olive AJ; Soltes G; Russell ML; Limmathurotsakul D; Norton RE; Ni SX; Picking WD; Jackson PJ; Stewart DI; Tsvetnitsky V; Picking WL; Cherwonogrodzky JW; Ketheesan N; Peacock SJ; Wiersma EJ
    FEMS Immunol Med Microbiol; 2008 Jan; 52(1):78-87. PubMed ID: 17995960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of signature-tagged mutagenesis in Burkholderia pseudomallei to identify genes important in survival and pathogenesis.
    Cuccui J; Easton A; Chu KK; Bancroft GJ; Oyston PC; Titball RW; Wren BW
    Infect Immun; 2007 Mar; 75(3):1186-95. PubMed ID: 17189432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Burkholderia pseudomallei Δasd mutant exhibits attenuated intracellular infectivity and imparts protection against acute inhalation melioidosis in mice.
    Norris MH; Propst KL; Kang Y; Dow SW; Schweizer HP; Hoang TT
    Infect Immun; 2011 Oct; 79(10):4010-8. PubMed ID: 21807903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melioidosis vaccines.
    Warawa J; Woods DE
    Expert Rev Vaccines; 2002 Dec; 1(4):477-82. PubMed ID: 12901586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application.
    Lankelma JM; Wagemakers A; Birnie E; Haak BW; Trentelman JJA; Weehuizen TAF; Ersöz J; Roelofs JJTH; Hovius JW; Wiersinga WJ; Bins AD
    Virulence; 2017 Nov; 8(8):1683-1694. PubMed ID: 28323523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model of immunity to Burkholderia pseudomallei: unique responses following immunization and acute lethal infection.
    Ulett GC; Labrooy JT; Currie BJ; Barnes JL; Ketheesan N
    Microbes Infect; 2005; 7(11-12):1263-75. PubMed ID: 16027024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of peptide mimotopes of Burkholderia pseudomallei exopolysaccharide.
    Legutki JB; Nelson M; Titball R; Galloway DR; Mateczun A; Baillie LW
    Vaccine; 2007 Nov; 25(45):7796-805. PubMed ID: 17935838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis.
    Stevens MP; Haque A; Atkins T; Hill J; Wood MW; Easton A; Nelson M; Underwood-Fowler C; Titball RW; Bancroft GJ; Galyov EE
    Microbiology (Reading); 2004 Aug; 150(Pt 8):2669-2676. PubMed ID: 15289563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase receptor is necessary for bacterial defense against pneumonia-derived septic melioidosis by facilitating phagocytosis.
    Wiersinga WJ; Kager LM; Hovius JW; van der Windt GJ; de Vos AF; Meijers JC; Roelofs JJ; Dondorp A; Levi M; Day NP; Peacock SJ; van der Poll T
    J Immunol; 2010 Mar; 184(6):3079-86. PubMed ID: 20142364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against heterologous Burkholderia pseudomallei strains by dendritic cell immunization.
    Elvin SJ; Healey GD; Westwood A; Knight SC; Eyles JE; Williamson ED
    Infect Immun; 2006 Mar; 74(3):1706-11. PubMed ID: 16495542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.